Scarica l'app Stockscreener
48.55
0.61%
-0.30
Dopo l'orario di chiusura:
48.49
-0.06
-0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$48.85
Aprire:
$49.45
Volume 24 ore:
20.19M
Relative Volume:
1.10
Capitalizzazione di mercato:
$72.16B
Reddito:
$20.62B
Utile/perdita netta:
$3.56B
Rapporto P/E:
20.36
EPS:
2.3847
Flusso di cassa netto:
$3.48B
1 W Prestazione:
+0.50%
1M Prestazione:
-13.27%
6M Prestazione:
-50.22%
1 anno Prestazione:
-52.79%
Intervallo 1D:
$48.27
$50.14
Intervallo di 1 settimana:
$47.16
$50.14
Portata 52W:
$47.16
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
48.55 | 72.61B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
91.07 | 158.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.66 | 115.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
81.67 | 105.19B | 36.36B | 4.84B | 5.43B | 3.7212 |
EW
Edwards Lifesciences Corp
|
85.96 | 50.35B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Corp (CHIX:BSXd) Competitors 2026 - GuruFocus
Boston Scientific Corp (CHIX:BSXd) Stock Price, Trades & News - GuruFocus
Is Boston Scientific Corporation (BSX) One of the Top Cheap Stocks With Strong Buy Ratings on Wall Street? - Insider Monkey
How Investors May Respond To Boston Scientific (BSX) Strong Q1 Beat But Cut Guidance On Watchman Growth - Yahoo Finance
$BSX StockBoston Scientific Corp | Quick Financials | LAST 12 YEARS Fulham Vs Bournemouth (HNvQmq85Ml) - Mshale
Boston Scientific stock: Is BSX underperforming the healthcare sector? - MSN
Truist cuts Boston Scientific stock price target on Watchman slowdown - Investing.com UK
Boston Scientific (BSX) Rises Higher Than Market: Key Facts - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corp. stock (US10117L1017): Indiana expansion and sector backdrop in focus - AD HOC NEWS
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
Boston Scientific plans to build $138M facility, hire 300 in Plainfield - Inside INdiana Business
Marietta medical startup gets $1.5 billion investment from Boston company - The Business Journals
UPDATE: Boston Scientific plans to build $138M facility, hire 300 in Plainfield - Indianapolis Business Journal
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
Why Boston Scientific Faces New Questions Across Healthcare - Kalkine Media
BTIG cuts Boston Scientific stock price target on Watchman sales outlook - Investing.com Nigeria
How A Quiet Reset Is Shaping The Boston Scientific (BSX) Investment Story - Yahoo Finance
FRACTURE IDE Success Adds Clinical Support To Boston Scientific Valuation Case - Yahoo Finance
Peripheral Vascular Devices Market by Type, End User - GlobeNewswire Inc.
Deals tracker: Ohio hospital, OhioHealth drop merger plans - Modern Healthcare
Boston Scientific Stock: Is BSX Underperforming the Healthcare Sector? - Barchart.com
Why Did BSX, LOW, CAG Fall To 52-Week Lows Today? - TradingView
Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & SuppliesDiversified Stocks In Q1 - Yahoo Finance
Boston Scientific (NYSE: BSX) CEO gifts 386,755 shares to irrevocable trust - Stock Titan
Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers - Yahoo Finance
Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform - Insider Monkey
Canaccord lowers Boston Scientific stock price target on Watchman slowdown - Investing.com
BSX Stock Price, Quote & Chart | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Why Did BSX, LI, ROL Stocks Fall To 52-Week Lows On Friday? - TradingView
Boston Scientific Corp. stock (US10117L1017): Wolfe Research downgrade in focus as shares trade near - AD HOC NEWS
Zscaler, AutoZone, And Regencell Are Among Top 10 Large-Cap Losers Last Week (May 25-May 29): Are The Others In Your Portfolio? - Benzinga
BSX Stock | Boston Scientific Corp Q3 2021 Earnings Call Frederik Andersen (UDFIjtx214) - Mshale
Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation - ChartMill
Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition - Yahoo Finance
Boston Scientific (BSX) Experiences Significant Options Activity on Thursday - GuruFocus
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Unusual Options Activity Points to Boston Scientific Stock as a Hot M&A Target - Barchart.com
Boston Scientific Corp ($BSX) Q2 2025 Earnings Call Slushi Twist (3k72Vx1f7J) - Mshale
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MSN
BSX Downgraded by Wolfe Research -- Rating Changed to Peer Perfo - GuruFocus
BSX vs. ABT: Which Medical Stock Has More Upside Potential? - TradingView
Wolfe Research cuts Boston Scientific rating as key growth drivers falter - Investing.com Nigeria
Wolfe Research downgrades Boston Scientific stock rating on growth concerns - Investing.com
Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare News
Why Boston Scientific Stock Was Sliding This Week - The Motley Fool
Barclays Remains a Buy on Boston Scientific (BSX) - The Globe and Mail
Our Boston Scientific Pick Has Suffered. We’re Pulling the Recommendation. - Barron's
Federated Hermes Kaufmann Fund II's Boston Scientific Corp(BSX) Holding History - GuruFocus
Assessing Boston Scientific (BSX) Valuation After Strong SEISMIQ 4CE Trial Results - simplywall.st
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.70%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):